This inventor holds 4 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2005-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maharashtra, IN (2005)
- Hyderabad, IN (2019 - 2020)
Company Filing History:
Years Active: 2005-2026
Title: Chitta Ranjan Patra: Innovator in Nanotechnology for Cancer Therapy
Introduction
Chitta Ranjan Patra is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of nanotechnology, particularly in the development of innovative formulations for cancer therapy. With a total of 4 patents to his name, Patra's work focuses on utilizing nanoparticles for targeted drug delivery systems.
Latest Patents
One of his latest patents involves a gold nanoparticle-based formulation designed for use in cancer therapy. This invention relates to the development of a new formulation containing gold nanoparticles (AuNPs) combined with bi-functional recombinant fusion proteins TRAF(C) for the delivery of anticancer drugs and nucleic acids specifically to HER2+ cancers. The targeted drug delivery system (TDDS) he designed, known as Au-TR-DX-si, integrates AuNPs with the recombinant fusion protein TRAF(C), doxorubicin, and siRNA. The stability and homogeneity of these formulations have been confirmed through various physicochemical studies. Additionally, the engineered fusion protein TRAF(C) selectively targets HER2+ receptors that are overexpressed in ovarian cancer cells.
Another notable patent focuses on highly biocompatible or nontoxic PVP (poly(n-vinyl-2-pyrrolidone)) coated silver prussian blue nanoparticles (SPB-NPs). These nanoparticles have been thoroughly characterized and exhibit remarkable stability in various physiological buffers. They demonstrate biocompatibility towards normal cells while significantly inhibiting the proliferation of different cancer cells in vitro. Furthermore, the SPB-NPs show excellent antibacterial activity against both gram-negative and gram-positive bacteria, indicating their potential as alternative anti-cancer and antibacterial agents.
Career Highlights
Chitta Ranjan Patra is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in nanotechnology and its applications in medicine. His innovative work has garnered attention in the scientific community, contributing to the ongoing fight against cancer and infectious diseases.
Collaborations
Patra has collaborated with notable colleagues such as Sudip Mukherjee and Vijaya Gopal, enhancing the scope and impact of his research endeavors.
Conclusion
Chitta Ranjan Patra's contributions to nanotechnology and cancer therapy exemplify the potential of innovative
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile